Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2000, p. 1032-1035, Vol. 38, No. 3
Special Project Unit, Bureau of Microbiology,
Canadian Science Centre for Human and Animal Health, Winnipeg,
Manitoba, Canada
Received 30 August 1999/Returned for modification 27 October
1999/Accepted 5 December 1999
A multiplex PCR assay for detection of genes for staphylococcal
enterotoxins A to E (entA, entB,
entC, entD, and entE), toxic shock
syndrome toxin 1 (tst), exfoliative toxins A and B
(etaA and etaB), and intrinsic methicillin
resistance (mecA) was developed. Detection of
femA was used as an internal positive control. The multiplex PCR assay combined the primers for sea to
see and femA in one set and those for
eta, etb, tst, mecA,
and femA in the other set. Validation of the assay was
performed using 176 human isolates of Staphylococcus
aureus. This assay offers a very specific, quick, reliable, and
inexpensive alternative to conventional PCR assays used in clinical
laboratories to identify various staphylococcal toxin genes.
It is well documented that strains
of Staphylococcus aureus produce a variety of extracellular
protein toxins, including enterotoxins, toxic shock syndrome toxin 1 (TSST-1), exfoliative toxin (ET), hemolysins, and coagulase
(15). S. aureus is one of the most commonly found
pathogenic bacteria and is hard to eliminate from the human
environment. It is responsible for many nosocomial infections, besides
being the main causative agent of food intoxication by virtue of its
variety of enterotoxins (15).
According to serological classification, to date six staphylococcal
enterotoxin (SE) groups have been recognized: SEA, SEB, SEC, SED, and
SEE (15) and the recently described SEH (22, 27).
These enterotoxins are small peptides (26 to 29 kDa) and have a great
deal of similarity at the amino acid level (21). They are
the main source of food poisoning and cause intensive intestinal
peristalsis. The toxic shock syndrome of humans and animals is caused
by the presence of S. aureus isolates producing TSST-1. The
enterotoxins, as well as TSST-1, belong to a family of superantigens
(25). The two ETs ETA and ETB, in conjunction or
independently, are implicated in the cause of staphylococcal scalded-skin syndrome (15).
Over the last few decades, there has been an enormous increase and
emergence of S. aureus strains resistant to the antibiotic methicillin (MRSA strains), particularly in nosocomial settings (13). The intrinsic resistance to these antibiotics is
attributed to the presence of mecA, whose product is a
78-kDa protein called penicillin binding protein 2a (14,
28). Identification of mecA in such MRSA strains has
led to some knowledge regarding the use of the antibiotic vancomycin
(9). The femA gene encodes a factor which is
essential for methicillin resistance and is universally present in all
S. aureus isolates. The femA gene product, a
48-kDa protein, has been implicated in cell wall metabolism and is
found in large amounts in actively growing cultures (17, 29).
For epidemiological surveillance, the methods most frequently used for
the detection of staphylococcal toxins are immunodiffusion, agglutination, radioimmunoassay, and enzyme-linked immunosorbent assay
(15, 18). Among the techniques used to identify toxin genotypes, DNA-DNA hybridization and PCR have been reported to be very
successful and reliable, and our laboratory previously designed
specific primers for the successful and reliable detection of SEs,
TSST-1, and ETs by PCR (18).
There are several reports in the literature describing the use of
multiplex PCR for detection of MRSA strains, but most of these
techniques are designed to detect only two or three gene fragments
(1, 8, 12, 24, 26, 29, 30). In this report, we describe two
multiplex PCR primer sets which can detect the presence of 10 staphylococcal genes simultaneously, in just two reactions. As an
internal positive control for each reaction, we incorporated primers
specifically designated to amplify femA, which has been
reported to be specific to S. aureus (29).
Validation of the multiplex PCR primers was performed and interpreted
using 176 isolates of S. aureus which were first
characterized for their toxin gene profiles by using individual primers
(18). We conclude that the multiplex primer sets described
here are reliable and specific in detecting the toxin genes of S. aureus.
Bacterial strains and culture media.
A total of 176 S. aureus strains were used in this study. Of these, 107 strains were
isolated from nasal swabs of a control (healthy) population, 47 strains
were from The Netherlands, and 19 MRSA strains were from a national
surveillance study in Canada. The remaining three strains were isolated
from clinical specimens. All strains were stored on suitable
maintenance media in the culture collection in the National Laboratory
for Bacteriology, Laboratory Center for Disease Control. The control
strains had been previously defined in terms of toxigenicity with
respect to enterotoxins, ETs, and TSST-1. The following strains were
used as positive controls in this study: ATCC 13565 (SEA), ATCC 14458 (SEB), ATCC 19095 (SEC), 90-S-1025 (SED), ATCC 27664 (SEE), 88-S-8902
(ETA), 88-S-8620 (ETB), 92-S-1344 (TSST-1), and 95-S-739
(mecA). The non-ATCC strains mentioned above were obtained
from the culture collection of the Laboratory Center for Disease
Control and were characterized for their toxin production by using
semiquantitative reversed passive latex agglutination toxin detection
kits (SET-RPLA and TST-RPLA; Oxoid Ltd., Basingstoke, Hampshire,
England). The two ET-producing strains were originally identified by
immunodiffusion tests (18). Disk diffusion tests for MRSA
isolates were performed as described previously (21a).
Bacterial cultures were grown in brain heart infusion broth prior to
extraction of total DNA.
DNA isolation.
Total DNA was isolated from 0.5 ml of brain
heart infusion broth culture grown overnight for all the bacterial
strains used in the study. The procedure used for DNA isolation has
been described previously (18). DNA samples were dissolved
in Tris-EDTA buffer (10 mM Tris chloride, 1 mM EDTA [pH 8.0]), and
the concentration was determined as micrograms per milliliter according
to A260 values. Template DNA in amounts ranging
from 10 to 1,000 ng was used in the study.
Primers.
Oligonucleotides ranging from 18- to 24-mers were
selected from the published DNA sequences of the S. aureus
genes (Table 1) using Oligo software
(version 3.4). Synthesis of oligonucleotides was carried out at the DNA
Core Facility at the Laboratory Center for Disease Control. For
multiplex PCRs, two primers sets were prepared: set A was designed to
amplify sea, seb, sec, sed,
see, and femA, whereas set B was designed to
amplify mecA, eta, etb, and
tst as well as femA. The primer sequences used in
the multiplex PCRs are described in Table 1.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Multiplex PCR for Detection of Genes for
Staphylococcus aureus Enterotoxins, Exfoliative Toxins,
Toxic Shock Syndrome Toxin 1, and Methicillin Resistance
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Nucleotide sequences, gene locations, and anticipated
sizes of PCR products for the S. aureus gene-specific
oligonucleotide primers used in this study
Multiplex PCR conditions. Two sets of primer mixes were prepared according to the master mixes of components from the GeneAmp kit (Perkin-Elmer, Norwalk, Conn.), with slight modifications to the given instructions. Multiplex primer set A contained 200 µM deoxynucleoside triphosphates; 5 µl of 10× reaction buffer (100 mM Tris-HCl [pH 8.3], 500 mM KCl); 1.5 mM MgCl2; 20 pmol (each) of sea, seb, sec, see, and femA primers; 40 pmol of sed primer; 2.5 U of Taq DNA polymerase (AmpliTaq DNA polymerase; Perkin-Elmer), and 10 to 1,000 ng of template DNA. The volume of this mix was adjusted to 50 µl with sterile water. Multiplex primer set B included the same constituents as in set A except for the MgCl2 concentration (2.0 mM) and the primers, which were used at 50 pmol for eta and 20 pmol each for etb, tst, mecA, and femA. Evaporation of the reaction mixture was prevented by addition of 100 µl of sterile mineral oil. DNA amplification was carried out in a Perkin-Elmer thermocycler with the following thermal cycling profile: an initial denaturation at 94°C for 5 min was followed by 35 cycles of amplification (denaturation at 94°C for 2 min, annealing at 57°C for 2 min, and extension at 72°C for 1 min), ending with a final extension at 72°C for 7 min.
| |
RESULTS |
|---|
|
|
|---|
Multiplex PCR for detection of selected staphylococcal genes.
The reaction conditions for the multiplex PCR assay were optimized to
ensure that all of the target gene sequences were satisfactorily amplified. The primers were designed to target the coding regions of
the genes; care was taken to avoid areas of homology within the
structural genes for the enterotoxins. The primers used in each set had
almost equal annealing temperatures, which reduced the possibility of
occurrence of unwanted bands originating from nonspecific
amplification. Figure 1 shows the
presence of the amplified products after agarose gel electrophoresis,
when DNA extracted from a representative toxigenic S. aureus
strain (positive control) was used as the template in the PCR using the
multiplex primer sets. Reliable amplification of six bands in set A
(for sea, seb, sec, sed,
see, and femA) was obtained when a mixture of
DNAs from the same strains was tested (Fig. 1). Similarly, five bands
were obtained when a mixture of DNAs from the corresponding strains in
set B (for eta, etb, tst,
mecA, and femA) was tested (Fig. 1). The sizes of
the amplicons obtained from the various control strains corresponded to
the predicted sizes (Table 1). As a negative control, both sets were
tested with sterile water, and no amplicons were observed (Fig. 1).
Genomic DNA in amounts ranging from 10 to 1,000 ng/reaction was used,
with no apparent change in sensitivity and ability to detect all of the
genes in the sample (data not shown).
|
Primary validation of the amplicons.
The sizes of the
amplicons obtained by the multiplex primer sets were identical to those
predicted from the design of the primers (Tables 1 and
2). The amplicons from the control
strains were subjected to further confirmation and characterization by digestion with restriction endonucleases with cleavage sites within the
amplicon. The restriction enzymes used and the predicted product sizes
are given in Table 2. Enzyme fragments with the anticipated sizes were
obtained in each case (data not shown).
|
Analysis of the results. Among the 176 strains tested, 107 strains were collected from nasal swabs of healthy humans. Of these 107 strains, 21 (19.6%) were positive for sea, 26 (24.3%) were positive for the TSST-1 gene (tst), 6 (5.6%) were found to be seb positive, 8 (7.5%) were positive for sec, and 2 (1.9%) contained the gene for sed. None were positive for see, eta, etb, or mecA. Of the 47 strains obtained from The Netherlands, 6 were positive for sea, 1 was positive for seb, 3 were positive for sec, 4 were positive for eta, and 11 were positive for tst. Among the three clinical isolates tested, all were positive for eta as well as etb.
Among the 19 strains obtained from the national MRSA surveillance study, 18 were mecA positive, indicating that mecA is responsible for methicillin resistance in those strains. The single remaining oxacillin-resistant isolate (which was mecA negative) must be methicillin resistant by virtue of some other mechanism (9). Of these MRSA isolates, three were positive for sea, two were positive for seb, three were positive for sec, two were positive for sed, three were positive for see, and one contained the gene for TSST-1. All of the 176 samples tested contained the femA gene.| |
DISCUSSION |
|---|
|
|
|---|
We have described a multiplex PCR-based diagnostic protocol to detect the genes for enterotoxins A to E, ETA, ETB, and TSST-1 and the mecA gene in DNA extracted from human isolates of S. aureus. This procedure is an improvement over our previously described PCR protocols, where individual primers were used to identify the staphylococcal toxin genes (18). The multiplex PCR primer sets were shown to be very specific, reliable, and, most importantly, very efficient in detection of all 10 genes. As an internal control, femA was found to be present in all of the strains studied. The gene product of femA has been suggested to have a role in cell wall metabolism and is reported to be present in all S. aureus species during the active growth phase (17, 29).
Six pairs of primers were used in multiplex primer set A to target the structural genes for enterotoxins A to E (sea, seb, sec, sed, and see), along with femA. In the multiplex primer set B, five pairs of primers were mixed together to target the structural genes for mecA, eta, etb, and tst, along with femA. All of the primers were gene specific, as demonstrated by restriction fragment lengths obtained after specific restriction endonuclease digestion of the amplicons. The multiplex primers were shown to be specific for S. aureus, since no amplification product was obtained when either C. jejuni or E. coli DNA was used as the template.
In this study, the toxin genotypes of S. aureus strains isolated from healthy human carriers are also demonstrated. Of 107 such isolates tested, 24.3% possessed the gene for TSST-1 and 19.6% were positive for SEA. These results are in accordance with previous findings that many healthy individuals are carriers of toxin-producing strains of S. aureus (10).
The use of multiplex PCR to characterize staphylococcal strains and their resistance to methicillin has been well documented (1, 8, 12, 29, 30). Those reports focus on detection of the gene responsible for methicillin resistance (mecA) along with either the femA, 16S rRNA, nuc, or IS431 gene as a positive control(s) (1, 8, 12, 29). A recent study describes the use of two multiplex PCR assays for detection of S. aureus exotoxin genes: one is designed to detect the enterotoxin genes, and the other is designed to detect the tst, eta, and etb genes (3). Becker et al. have used DNA enzyme immunoassays to validate the specificity of the PCR products, using oligonucleotide probes derived from the sequences of the S. aureus toxin genes (3).
The study described in this paper provides detailed information about S. aureus toxin genes as well as mecA. The inclusion of an internal positive control (femA) in the reaction provides assurance against false-negative results. Use of this multiplex PCR assay will help provide the information required for appropriate therapy and infection control during outbreaks of S. aureus. It is important to recognize that this technique only will identify strains harboring the toxin genes and is independent of the expression and secretion of the toxin. To verify toxin production by any given isolate, time- and labor-intensive immunological methods may be used to detect the excreted toxins.
Considering the low cost and much shorter time required to detect the 10 genes of S. aureus by multiplex PCR, we believe this to be a powerful tool for studying the genotypes of staphylococcal isolates. This procedure was specially developed to fit into the daily work pattern of a routine clinical laboratory, since genotypic detection of drug resistance and the presence of toxin genes is becoming an important component of the diagnostic inventory of such laboratories.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to J. W. Cohen Tervaert for the strains from The Netherlands and to M. Mamelak for the strains from healthy controls. We also thank Russell Easy and Hugh Cai for technical assistance and M. R. Mulvey for critical review and reading of the manuscript.
M.M. was funded by a postdoctoral fellowship from a grant to W.M.J. by the Canadian Bacterial Disease Network.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Cangene Corporation, 26 Henlow Bay, Winnipeg, Manitoba, Canada R3Y 1G4. Phone: (204) 275-4301. Fax: (204) 275-4289. E-mail: wjohnson{at}cangene.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barski, P., L. Piechowicz, J. Galinski, and J. Kur. 1996. Rapid assay for detection of methicillin-resistant Staphylococcus aureus using multiplex PCR. Mol. Cell. Probes 10:471-475[CrossRef][Medline]. |
| 2. |
Bayles, K. W., and J. J. Iandolo.
1989.
Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D.
J. Bacteriol.
171:4799-4806 |
| 3. |
Becker, K.,
R. Roth, and G. Peters.
1998.
Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin gene.
J. Clin. Microbiol.
36:2548-2553 |
| 4. | Berger-Bachi, B., L. Barberis-Maino, A. Strassle, and F. H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219:263-269[CrossRef][Medline]. |
| 5. |
Betley, M. J., and J. J. Mekalanos.
1988.
Nucleotide sequence of the type A staphylococcal enterotoxin gene.
J. Bacteriol.
170:34-41 |
| 6. |
Blomster-Hautamaa, D. A.,
B. N. Kreiswirth,
J. S. Kornblum,
R. P. Novick, and P. M. Schlievert.
1986.
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1.
J. Biol. Chem.
261:15783-15786 |
| 7. | Bohach, G. A., and P. M. Schlievert. 1987. Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol. Gen. Genet. 209:15-20[CrossRef][Medline]. |
| 8. | Brakstad, O. G., J. A. Maeland, and Y. Tveten. 1993. Multiplex polymerase chain reaction for detection of genes for Staphylococcus aureus thermonuclease and methicillin resistance and correlation with oxacillin resistance. APMIS 101:681-688[Medline]. |
| 9. | Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791[Abstract]. |
| 10. | Chance, T. D. 1996. Toxic shock syndrome: role of the environment, the host and the microorganism. Br. J. Biomed. Sci. 53:284-289[Medline]. |
| 11. |
Couch, J. L.,
M. T. Soltis, and M. J. Betley.
1988.
Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene.
J. Bacteriol.
170:2954-2960 |
| 12. |
Geha, D. L.,
J. R. Uhl,
C. A. Gustaferro, and D. H. Persing.
1994.
Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory.
J. Clin. Microbiol.
32:1768-1772 |
| 13. | Haley, R. W., A. W. Hightower, R. F. Khabbaz, C. Thorsberry, W. J. Martone, J. R. Allen, and J. M. Hughes. 1982. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Ann. Intern. Med. 97:297-308. |
| 14. |
Hartman, B. J., and A. Tomasz.
1984.
Low-affinity binding protein associated with beta-lactam resistance in Staphylococcus aureus.
J. Bacteriol.
158:513-516 |
| 15. | Iandolo, J. J. 1989. Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu. Rev. Microbiol. 43:375-402[CrossRef][Medline]. |
| 16. |
Jackson, M. P., and J. J. Iandolo.
1986.
Sequence of the exfoliative toxin B gene of Staphylococcus aureus.
J. Bacteriol.
167:726-728 |
| 17. | Johnson, S., K. Dominique, and H. Labischinski. 1995. FemA of Staphylococcus aureus: isolation and immunodetection. FEMS Microbiol. Lett. 132:221-228[CrossRef][Medline]. |
| 18. |
Johnson, W. M.,
S. D. Tyler,
E. P. Ewan,
F. E. Ashton,
D. R. Pollard, and K. R. Rozee.
1991.
Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction.
J. Clin. Microbiol.
29:426-430 |
| 19. |
Jones, C. L., and S. A. Khan.
1986.
Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus.
J. Bacteriol.
166:29-33 |
| 20. |
Lee, C. Y.,
J. J. Schmidt,
A. D. Johnson-Winegar,
L. Spero, and J. J. Iandolo.
1987.
Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus.
J. Bacteriol.
169:3904-3909 |
| 21. |
Marrack, P., and J. Kappler.
1990.
The staphylococcal enterotoxins and their relatives.
Science
248:705 |
| 21a. | National Committee for Clinical Laboratory Standards. 1993. Document M2-A5. Performance standards for antimicrobial disk susceptibility tests, 5th ed. National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 22. |
Ren, K.,
J. D. Bannan,
V. Pancholi,
A. L. Cheung,
J. C. Robbins,
V. A. Fischetti, and J. B. Zabriskie.
1994.
Characterization and biological properties of a new staphylococcal exotoxin.
J. Exp. Med.
180:1675-1683 |
| 23. | Ryffel, C., W. Tesch, I. Birch-Machin, P. E. Reynolds, L. Barberis-Maino, F. H. Kayser, and B. Berger-Bachi. 1990. Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene 94:137-138[CrossRef][Medline]. |
| 24. | Salisbury, S. M., L. M. Sabatini, and C. A. Spiegel. 1997. Identification of methicillin-resistant staphylococci by multiplex polymerase chain reaction assay. Am. J. Clin. Pathol. 107:368-373[Medline]. |
| 25. | Schlievert, P. M. 1993. Role of superantigens in human diseases. J. Infect. Dis. 167:997-1002[Medline]. |
| 26. |
Schmitz, F.-J.,
C. R. Mackenzie,
B. Hofmann,
J. Verhoef,
M. Finken-Eigen,
H.-P. Heinz, and K. Kohrer.
1997.
Specific information concerning taxonomy, pathogenicity, and methicillin resistance of staphylococci obtained by a multiplex PCR.
J. Med. Microbiol.
46:773-778 |
| 27. | Su, Y., and A. C. Lee Wong. 1995. Identification and purification of a new staphylococcal enterotoxin, H. Appl. Environ. Microbiol. 61:1438-1443[Abstract]. |
| 28. |
Utsui, Y., and T. Yokota.
1985.
Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
28:397-403 |
| 29. | Vannuffel, P., J. Gigi, H. Ezzedine, B. Vandercam, M. Delmee, G. Wauters, and J. Gala. 1995. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J. Clin. Microbiol. 33:2864-2867[Abstract]. |
| 30. | Zambardi, G., M. E. Reverdy, S. Bland, M. Bes, J. Freney, and J. Fleurette. 1994. Laboratory diagnosis of oxacillin resistance in Staphylococcus aureus by a multiplex-polymerase chain reaction assay. Diagn. Microbiol. Infect. Dis. 19:25-31[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»